Inventor · disambiguated record
Chien-Hung Yeh
Also filed as: YEH CHIEN-HUNG
6 granted patents·6 pending applications·29 citations·filing 2014–2024
82Inventor score
Top patents by PatentIndex Score
12 records- 0196US11028120B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Jun 8, 2021·10 cites·30 claims
- 0295US12018043B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·6 cites·33 claims
- 0395US11130778B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Sep 28, 2021·8 cites·30 claims
- 0494US11530236B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·4 cites·25 claims
- 0587US12454544B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2024·Granted Oct 28, 2025·0 cites·9 claims
- 0679US2025092025A1Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their useCARMOT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0770US2023089073A1Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their useCARMOT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0870US2024252492A1Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their useCARMOT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0964US9409931B13-O-acyl-ingenol analoguesLEO LABORATORIES LTD·Filed 2015·Granted Aug 9, 2016·1 cites·13 claims
- 1062US2024262811A1Benzimidazoyl glp-1 receptor agonists, pharmaceutical compositions comprising the same, and methods for their useCARMOT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1162US2022396569A1Benzimidazoyl glp-1 receptor agonists, pharmaceutical compositions comprising the same, and methods for their useCARMOT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1243US2016107977A1Methods of synthesis of ingenol and intermediates thereofLEO LAB LTD·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chien-Hung Yeh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →